As of June 30, 2026, PureTech Health PLC carries a market capitalization of 437.47M, placing it among publicly traded companies globally. Its enterprise value stands at 227.67M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 437.47M |
| Enterprise Value | 227.67M |
PureTech Health PLC's next confirmed earnings release is scheduled for April 29, 2027.
| Earnings Date | 4/29/2027 |
As of June 30, 2026, PureTech Health PLC has 24.30M shares outstanding.
| Shares Outstanding | 24.30M |
These figures are as of June 30, 2026.
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.13 |
As of June 30, 2026, PureTech Health PLC maintains a current ratio of 4.60, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.60 |
| Quick Ratio | 4.03 |
| Debt / Equity | 4.82 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 66.00 |
As of the close on November 10, 2026, PureTech Health PLC's stock has declined approximately 6.31% over the past 52 weeks. The 50-day moving average sits at 15.89, while the 200-day moving average is 16.82.
| 52-Week Price Change | -6.31% |
| 50-Day Moving Average | 15.89 |
| 200-Day Moving Average | 16.82 |
As of June 30, 2026, PureTech Health PLC holds 221.36M in cash and equivalents against 18.31M in total debt, resulting in a net debt position of -115.90M. Total book value stands at 386.23M, with working capital of 197.46M providing operational flexibility.
| Cash & Cash Equivalents | 221.36M |
| Total Debt | 18.31M |
| Net Debt | -115.90M |
| Equity (Book Value) | 386.23M |
| Book Value Per Share | 15.89 |
| Working Capital | 197.46M |